Pharmaceutical News

RSS

Sacramento City Council approves sale of nonprescription needles

The Sacramento, Calif., City Council on Tuesday voted 6-2 to approve a measure that will allow the nonprescription sale of syringes to adults, the Sacramento Bee reports (Stern, Sacramento Bee, 9/6).

7 Sep 2006

FDA asks U.S. Marshals to seize dietary supplements

At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00.

6 Sep 2006

Sen. Santorum, opponent Casey differ in opinion of FDA approval of nonprescription Plan B sales

Sen. Rick Santorum and Pennsylvania Treasurer Bob Casey on Sunday on NBC's "Meet the Press showed "sharp" disagreement over FDA's recent approval of nonprescription sales of Barr Laboratories' emergency contraceptive Plan B.

5 Sep 2006

Some find Accutane iPledge program requirements burdensome

Six months after the introduction of iPledge -- with which all people taking the acne drug isotretinoin, sold by Roche under the brand name Accutane, must register to receive their prescriptions - many patients and dermatologists "complain that the rules of iPledge are onerous and unworkable

5 Sep 2006

Some drug companies experiencing higher prescription volume, revenue with Medicare drug benefit

The Philadelphia Inquirer on Monday examined how the Medicare prescription drug benefit "is boosting prescription volume and revenue for drug companies."

5 Sep 2006

Licensing arrangement reached for antiepileptic drug developed at Hebrew University

A worldwide licensing arrangement for development, production and marketing of an antiepileptic drug created at the Hebrew University of Jerusalem has been signed by Shire Pharmaceuticals with Yissum, the Hebrew University's technology transfer company.

5 Sep 2006

New drug improves blood flow in diseased arteries

A new drug has been shown to improve blood flow in diseased arteries, reducing the risk of high blood pressure and heart attacks, a Monash University study published today reveals.

4 Sep 2006

Sanofi pasteur begins shipping influenza vaccine

Sanofi pasteur, the vaccines business of the sanofi-aventis Group, began shipping influenza vaccine (Fluzone, Influenza Virus Vaccine) to the U.S. market for the 2006-2007 season.

4 Sep 2006

Emergent BioSolutions awarded $3.8 million to develop anthrax immune globulin therapeutic

Emergent BioSolutions has announced that it has been awarded two grants from the National Institute of Allergy and Infectious Diseases (NIAID) totaling $3.8 million to support the development of the company's anthrax immune globulin (AIG) therapeutic product.

1 Sep 2006

Washington State Gov. Gregoire proposes compromise that would allow individual pharmacists to refuse to fill prescription, nonprescription EC

Washington state Gov. Christine Gregoire (D) has proposed a compromise that would allow pharmacists to refuse to fill prescription and nonprescription emergency contraceptives only if the drugs can be provided by another pharmacist in the same pharmacy, the AP/Seattle Times reports.

1 Sep 2006

Some parents have difficulties gaining access to insurance coverage for HPV vaccine Gardasil

Some parents seeking to vaccinate their daughters with Merck's human papillomavirus vaccine Gardasil have experienced difficulty in obtaining it or getting it covered by health insurance, the AP/Seattle Post-Intelligencer reports (Tanner, AP/Seattle Post-Intelligencer, 8/29).

1 Sep 2006

March of Dimes urges FDA to approve Gestiva

The March of Dimes has urged Food and Drug Administration officials to promptly approve a commercial progesterone therapy that appears to prevent some premature births.

30 Aug 2006

Summary of editorials on approval of nonprescription plan B sales to women over age 18

Some editorials respond to FDA's decision on Thursday to approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B to women ages 18 and older.

30 Aug 2006

90% of dermatologists report having problems with Isotretinoin drug registry

The online FDA tracking database iPledge -- with which all people taking the acne drug isotretinoin, sold by Roche under the brand name Accutane, must register to receive their prescriptions -- has caused problems for about 90% of dermatologists.

30 Aug 2006

FDA advisory panel recommends approval of experimental preterm labor prevention drug

An FDA advisory committee on Tuesday voted 13-8 that clinical trial data regarding Adeza's experimental preterm labor prevention drug Gestiva was adequate to approve the drug, Dow Jones reports (Corbett Dooren, Dow Jones, 8/29).

30 Aug 2006

Schering-Plough to pay $435M and plead guilty to conspiracy

Schering-Plough on Tuesday agreed to pay $435 million and plead guilty to criminal conspiracy charges to settle a federal investigation into the company's marketing practices and Medicaid charges, the AP/Houston Chronicle reports (AP/Houston Chronicle, 8/30).

30 Aug 2006

FDA forms task force on human tissue safety

The Food and Drug Administration (FDA) today announced the formation of a multidisciplinary FDA task force on human cell and tissue safety.

30 Aug 2006

Ortho-McNeil to lower the price of contraceptive pills and patches

Ortho-McNeil - which supplies contraceptives to the majority of family planning clinics nationwide - on Thursday announced it will lower the price of its contraceptive pills and patches, according to officials, the Chicago Tribune reports.

30 Aug 2006

History of cervical cancer, HPV vaccine development

The New York Times on Tuesday examined the development of vaccines to prevent transmission of the human papillomavirus, which can cause cervical cancer.

30 Aug 2006

FDA questions effectiveness of Gestiva at preventing preterm labor

FDA in a review of Adeza's experimental preterm labor prevention drug Gestiva said the drug seems to reduce deliveries before 37 weeks' gestation but not births before 32 or 35 weeks' gestation, according to documents posted Monday on the agency's Web site.

30 Aug 2006

Pharmaceutical News

Sacramento City Council approves sale of nonprescription needles

FDA asks U.S. Marshals to seize dietary supplements

Sen. Santorum, opponent Casey differ in opinion of FDA approval of nonprescription Plan B sales

Some find Accutane iPledge program requirements burdensome

Some drug companies experiencing higher prescription volume, revenue with Medicare drug benefit

Licensing arrangement reached for antiepileptic drug developed at Hebrew University

New drug improves blood flow in diseased arteries

Sanofi pasteur begins shipping influenza vaccine

Emergent BioSolutions awarded $3.8 million to develop anthrax immune globulin therapeutic

Washington State Gov. Gregoire proposes compromise that would allow individual pharmacists to refuse to fill prescription, nonprescription EC

Some parents have difficulties gaining access to insurance coverage for HPV vaccine Gardasil

March of Dimes urges FDA to approve Gestiva

Summary of editorials on approval of nonprescription plan B sales to women over age 18

90% of dermatologists report having problems with Isotretinoin drug registry

FDA advisory panel recommends approval of experimental preterm labor prevention drug

Schering-Plough to pay $435M and plead guilty to conspiracy

FDA forms task force on human tissue safety

Ortho-McNeil to lower the price of contraceptive pills and patches

History of cervical cancer, HPV vaccine development

FDA questions effectiveness of Gestiva at preventing preterm labor

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News